Survivin: A molecular biomarker in cancer
PK Jaiswal, A Goel, RD Mittal - Indian Journal of Medical …, 2015 - journals.lww.com
Survivin, a member of the inhibitor of apoptosis (IAP) protein family that inhibits caspases
and blocks cell death, is highly expressed in most cancers and is associated with a poor …
and blocks cell death, is highly expressed in most cancers and is associated with a poor …
The survivin molecule as a double‐edged sword in cellular physiologic and pathologic conditions and its role as a potential biomarker and therapeutic target in cancer
A Rafatmanesh, M Behjati, N Mobasseri… - Journal of Cellular …, 2020 - Wiley Online Library
Survivin is a member of the family of apoptosis inhibitory proteins with increased expression
level in most cancerous tissues. Evidence shows that survivin plays regulatory roles in …
level in most cancerous tissues. Evidence shows that survivin plays regulatory roles in …
Survivin signaling in clinical oncology: a multifaceted dragon
Survivin is an inhibitor of apoptosis protein (IAP) family member preferentially expressed in a
myriad of clinical cancers. The complex functional mechanism and regulatory roles of …
myriad of clinical cancers. The complex functional mechanism and regulatory roles of …
BIRC5 Gene Polymorphisms Are Associated with a Higher Stage of Local and Regional Disease in Oral and Oropharyngeal Squamous Cell Carcinomas
Oral squamous cell carcinoma (OSCC) and oropharyngeal squamous cell carcinoma
(OPSCC) are the most common types of cancers in the head and neck region (HNSCC) …
(OPSCC) are the most common types of cancers in the head and neck region (HNSCC) …
Role of survivin gene promoter polymorphism (− 31G> C) in susceptibility and survival of esophageal cancer in northern India
R Upadhyay, R Khurana, S Kumar, UC Ghoshal… - Annals of surgical …, 2011 - Springer
Abstract Background and Aim Survivin is an upregulated inhibitor of apoptosis protein in
esophageal cancer (EC), and a promoter region polymorphism (− 31G> C) in the survivin …
esophageal cancer (EC), and a promoter region polymorphism (− 31G> C) in the survivin …
Two survivin polymorphisms are cooperatively associated with bladder cancer susceptibility
N Kawata, N Tsuchiya, Y Horikawa… - … journal of cancer, 2011 - Wiley Online Library
Abnormal survivin expression has been reported to be involved in many types of cancer. A
single‐nucleotide polymorphism (SNP), C‐31G, located in the promoter region of survivin …
single‐nucleotide polymorphism (SNP), C‐31G, located in the promoter region of survivin …
Overview of role of survivin in cancer: expression, regulation, functions, and its potential as a therapeutic target
X Fang, X Cao, J **ao, Y Hu, M Chen… - Journal of Drug …, 2024 - Taylor & Francis
Survivin holds significant importance as a member of the inhibitor of apoptosis protein (IAP)
family due to its predominant expression in tumours rather than normal terminally …
family due to its predominant expression in tumours rather than normal terminally …
Survivin gene polymorphism association with papillary thyroid carcinoma
Survivin expression is correlated with suppression of apoptosis in human solid tumors. A
polymorphism at position− 31 (G/C)(rs 9904341) has been associated with cancer risk in …
polymorphism at position− 31 (G/C)(rs 9904341) has been associated with cancer risk in …
[HTML][HTML] Polymorphisms in the survivin promoter are associated with age of onset of ovarian cancer
Survivin has been identified as an apoptosis inhibitor and a key regulator of mitosis. A
common polymorphism (-31G> C) at the survivin promoter has been extensively studied in …
common polymorphism (-31G> C) at the survivin promoter has been extensively studied in …
Survivin SNP-carcinogen Interactions in Oral Cancer
CJ Weng, YH Hsieh, MK Chen… - Journal of dental …, 2012 - journals.sagepub.com
In Taiwan, oral cancer is causally associated with environmental carcinogens. Survivin is an
anti-apoptotic protein and is generally considered a marker of malignancy. The current study …
anti-apoptotic protein and is generally considered a marker of malignancy. The current study …